Mersana Therapeutics's market cap is currently $45.86M. The company's EPS TTM is $-4.87; its P/E ratio is -0.66; Mersana Therapeutics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-1.54. See an overview of income statement, balance sheet, and cash flow financials.
